Search Results

Refine
1 - 5 of 5 Products for '577nm' Page 1 of 1 |
  • 1

577nm

Coherent

Coherent

…an application has led to the development of a high-power yellow (577nm) laser for the
treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases
associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of

Photonics Spectra - June 2017

Photonics Spectra - June 2017

…(e).
Figure 2. The effectiveness of STED is clear in this pair of images of fluorescently tagged microtubuli in
mammalian cells using a 577-nm laser to drive the STED effect: conventional confocal (left) and gated
STED image (right).
Zhen-li Huang, Wuhan National Laboratory for…

Bio Photonics - April 2015

Bio Photonics - April 2015


Figure 2. The effectiveness of STED is clear in this pair of images of fluorescently tagged
microtubuli in mammalian cells using a 577-nm Coherent Genesis laser to drive the STED
effect: conventional confocal (left) and gated STED image (right). Image courtesy of Dr. Giuseppe…

34706a cover.indd

34706a cover.indd

…an application has led to the development of a high-power yellow (577nm) laser for the
treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases
associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of

32311a coverSinglesRR.indd

32311a coverSinglesRR.indd

…an application has led to the development of a high-power yellow (577nm) laser for the
treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases
associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of

Powered by Site Search powered by SLI Systems

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions